<?xml-stylesheet type="text/xsl" href="https://www.vetsurgeon.org/utility/feedstylesheets/rss.xsl" media="screen"?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" xmlns:wfw="http://wellformedweb.org/CommentAPI/"><channel><title>New atopy claim for Cortavance</title><link>/b/veterinary-news/posts/new-atopy-claim-for-cortavance</link><description> Virbac has announced that Cortavance, the topical steroid containing HCA, for the symptomatic treatment of inflammatory and pruritic skin disorders in dogs, is now licensed for the control of the symptoms associated with atopy. 
 Virbac says HCA targets</description><dc:language>en-US</dc:language><generator>Telligent Community 10</generator></channel></rss>